Should expensive cancer treatments be reimbursed?

No fewer than 40,000 oncologists and researchers from around the world gathered in Chicago for the annual meeting of the American Society of Clinical Oncology (ASCO). This year, the watchword was immunotherapy, but this rapidly expanding territory comes at a price.